Neurosciences
Neurological disorders are very common and the symptoms can be devastating for tens of millions of Americans. Scientists in the North Shore-LIJ Health System and the Feinstein Institute for Medical Research,spend a great deal of resources on the study of conditions such as Alzheimer's disease, Parkinson's disease and other movement disorders, brain tumors and strokes.
Children Pages
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment and at Six Month Follow-up (11-196A)
- Autism Spectrum Disorders - Adult Study (07.04.051)
- Brain and Behavior in Dystonia: A Multicenter Study (03.02.079G)
- Brain and Behavior in Dystonia Study (08-283)
- Brain AVM - Clinical Trial (06.02.063)
- Brain Networks in Parkinson's Disease (04-113T)
- Cannabis - Dopamine Study - (09-002)
- Clinical Correlates of Memory Impairment (03.08.160)
- Dementia - Clinical Trial (08-295)
- Dystonia - Deep Brain Stimulation Study (06-109T)
- Epilepsy
- Epilepsy - Cognitive and Sensorimotor Study (07-125)
- Epilepsy - Genetic Marker and Enzyme Study (07.08.009)
- Epilepsy - Multicenter Study (06.08.058)
- Glioblastoma - Clinical Trial (08-06-234)
- Huntington's Disease - Clinical Trial (09-012)
- Huntington's Disease - Coenzyme Q10 Study (07-124)
- Laparoscopic Experience and Functional Brain Activation (07-106)
- Memory Disorders Study (08-219)
- Metastatic Brain Tumor Study (08-10-24)
- MIF - Spinal Cord Injury Study (09-026)
- Movement Disorders - Functional Correlates Study (08-191)
- Multiple Sclerosis - Diffusion Tensor MRI Correlates of Depression (03.02.084T)
- Neuroendocrine Tumors - Imaging Study (03-117)
- Parkinson's Disease Genetics Database (07-057)
- Parkinson's Disease - Genetic Study (07-058)
- Parkinson's Disease - Molecular Basis for Cognitive Impairment (06-108T)
- Parkinson's Disease - Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel (B09-004)
- Parkinson’s Disease - Early Differential Diagnosis of Parkinsonism with Metabolic Imaging and Pattern Analysis
- Parkinson’s Disease - Efficacy, Safety, and Tolerability of Pioglitazone
- Parkinson’s Disease - Efficacy, Safety and Tolerability of CoganeTM (B10-046)
- Parkinson’s Disease - Efficacy and Safety of Sufinamide (B10-026)
- Parkinson’s Disease - Efficacy and Safety Study of Low and High Doses of Safinamide (10-02-48-031)
- Parkinson’s Disease - Metabolic Networks and the Cognitive Treatment Response in Parkinson’s Disease
- Parkinson’s Disease - Microvascular Changes in Parkinson’s Disease: Relationship to Levodopa-Induced Dyskinesia
- Parkinson’s Disease - Open-Label Continuation Treatment Study with Levodopa-Carbidopa Intestinal Gel (B10-039)
- Pitch Recognition in Autistic Spectrum Disorders (04-053)
- REM Behavior Disorder and Parkinsonism: Longitudinal PET Study (08-126)
- Schizophrenia-like Effects of Cannibinoids (09-157)
- Swallowing Therapy Study (07-130)
- Web-delivery Treatment for Substance Abuse (10-016A)
Last Update
September 28, 2009How did I get to this page?
General Navigation
Persistent Navigation
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Dental
- Diabetes
- Ear & Hearing
- Eyes
- Gastrointestinal/Hepatitis
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
- Lupus
- Men's Health
- Mental Health
- Neurosciences
- Recruitment Registry
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health